Congenital fibrinogen deficiencyAfibrinogenemia; Hypofibrinogenemia; Dysfibrinogenemia
Congenital fibrinogen deficiency is a very rare, inherited blood disorder in which the blood does not clot normally. It affects a protein called fibrinogen. This protein is needed for the blood to clot.
This disease is due to abnormal genes. Fibrinogen is affected depending on how the genes are inherited:
- When the abnormal gene is passed down from both parents, a person will have a complete lack of fibrinogen (afibrinogenemia).
- When the abnormal gene is passed down from one parent, a person will have either a reduced level of fibrinogen (hypofibrinogenemia) or a problem with the function of fibrinogen (dysfibrinogenemia). Sometimes, these two fibrinogen problems can occur in the same person.
People with a complete lack of fibrinogen may have any of the following bleeding symptoms:
- Bruising easily
- Bleeding from the umbilical cord just after birth
- Bleeding in the mucous membranes
- Bleeding in the brain (very rare)
- Bleeding in the joints
- Heavy bleeding after injury or surgery
- Nosebleeds that do not stop easily
People with a reduced level of fibrinogen bleed less often and the bleeding is not as severe. Those with a problem with the function of fibrinogen often don't have symptoms.
Exams and Tests
If your health care provider suspects this problem, you will have lab tests to confirm the type and severity of the disorder.
- Bleeding time
- Fibrinogen test and reptilase time to check fibrin level and quality
- Partial thromboplastin time (PTT)
- Prothrombin time (PT)
- Thrombin time
The following treatments can be used for bleeding episodes or to prepare for surgery:
- Cryoprecipitate (a blood product containing concentrated fibrinogen and other clotting factors)
- Fibrinogen (RiaSTAP)
- Plasma (the liquid portion of the blood containing clotting factors)
People with this condition should get the hepatitis B vaccine. Having many transfusions raises your risk of getting hepatitis.
Hepatitis B vaccine
All content below is taken in its entirety from the CDC Hepatitis B Vaccine Information Statement (VIS): www. cdc. gov/vaccines/hcp/vis/vis-statement...
Excessive bleeding is common with this condition. These episodes may be severe, or even fatal. Bleeding in the brain is a leading cause of death in people with this disorder.
Complications may include:
- Blood clots with treatment
- Development of antibodies (inhibitors) to fibrinogen with treatment
- Gastrointestinal bleeding
- Rupture of the spleen
- Slow healing of wounds
When to Contact a Medical Professional
Call your provider or seek emergency care if you have excessive bleeding.
Tell your surgeon before you have surgery if you know or suspect you have a bleeding disorder.
This is an inherited condition. There is no known prevention.
Gailani D, Neff AT. Rare coagulation factor deficiencies. In: Hoffman R, Benz EJ Jr, Silberstein LE, Heslop HE, Weitz JI, Anastasi J, eds. Hematology: Basic Principles and Practice. 6th ed. Philadelphia, PA: Elsevier Saunders; 2013:chap 139.
Meeks SL. Congenital disorders of fibrinogen. In: Shaz BH, Hillyer CD, Roshal M, Abrams CS, eds. Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects. 2nd ed. Philadelphia, PA: Elsevier; 2013:chap 108.
Ragni MV. Hemorrhagic disorders: coagulation factor deficiencies. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 174.
Review Date: 2/1/2017
Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.